Melarsoprol (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Melarsoprol" in English language version.

refsWebsite

Global rank English rank

7web.archive.org

1^st place

5doi.org

2^nd place

5nih.gov

4^th place

5semanticscholar.org

11^th place

8^th place

3who.int

195^th place

302^nd place

2cdc.gov

218^th place

212^th place

1drugs.com

399^th place

333^rd place

1handle.net

102^nd place

76^th place

1antimicrobe.org

low place

1newscientist.com

774^th place

716^th place

1msf.org

low place

1books.google.com

3^rd place

antimicrobe.org

Pepin J (2014). "Trypanosoma brucei gambiense and Trypanosoma brucei rhodesiense (African Trypanosomiasis) - Infectious Disease and Antimicrobial Agents". antimicrobe.org. Archived from the original on 2016-11-28. Retrieved 2016-11-17.

books.google.com

Holtz A (2006). The Medical Science of House, M.D. Penguin. p. 272. ISBN 1440628734. Retrieved 25 March 2020.

cdc.gov

"Our Formulary". Infectious Diseases Laboratories. CDC. 22 September 2016. Archived from the original on 16 December 2016. Retrieved 7 December 2016.
CDC (2013). "Disease Control and Prevention: Parasites – African Trypanosomiasis". Archived from the original on 2017-06-19.

doi.org

Bisser S, N'Siesi FX, Lejon V, Preux PM, Van Nieuwenhove S, Miaka Mia Bilenge C, Būscher P (February 2007). "Equivalence trial of melarsoprol and nifurtimox monotherapy and combination therapy for the treatment of second-stage Trypanosoma brucei gambiense sleeping sickness". The Journal of Infectious Diseases. 195 (3): 322–329. doi:10.1086/510534. PMID 17205469. S2CID 10175400.
Kioy D, Jannin J, Mattock N (March 2004). "Human African trypanosomiasis". Nature Reviews. Microbiology. 2 (3): 186–187. doi:10.1038/nrmicro848. PMID 15751187. S2CID 36525641.
Brun R, Schumacher R, Schmid C, Kunz C, Burri C (November 2001). "The phenomenon of treatment failures in Human African Trypanosomiasis". Tropical Medicine & International Health. 6 (11): 906–914. doi:10.1046/j.1365-3156.2001.00775.x. PMID 11703845. S2CID 21542129.
Keiser J, Ericsson O, Burri C (May 2000). "Investigations of the metabolites of the trypanocidal drug melarsoprol". Clinical Pharmacology and Therapeutics. 67 (5): 478–488. doi:10.1067/mcp.2000.105990. PMID 10824626. S2CID 24326873.
Maudlin I (December 2006). "African trypanosomiasis". Annals of Tropical Medicine and Parasitology. 100 (8). Taylor & Francis: 679–701. doi:10.1179/136485906x112211. PMID 17227648. S2CID 19567898. ...cites this study: Fèvre EM, Coleman PG, Odiit M, Magona JW, Welburn SC, Woolhouse ME (August 2001). "The origins of a new Trypanosoma brucei rhodesiense sleeping sickness outbreak in eastern Uganda". Lancet. 358 (9282). Elsevier BV: 625–628. doi:10.1016/s0140-6736(01)05778-6. PMID 11530149. S2CID 205937568.

drugs.com

"Melarsoprol Drug Information, Professional". Drugs.com. 20 December 1994. Archived from the original on 30 December 2016. Retrieved 7 December 2016.

handle.net

hdl.handle.net

World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.

msf.org

medicalguidelines.msf.org

"MELARSOPROL injectable - Essential drugs". medicalguidelines.msf.org. Retrieved 6 December 2019.

newscientist.com

Hollingham R (2005). "Curing diseases modern medicine has left behind". New Scientist. 2005 (2482): 40–41. Archived from the original on 2015-05-11.

nih.gov

pubmed.ncbi.nlm.nih.gov

Bisser S, N'Siesi FX, Lejon V, Preux PM, Van Nieuwenhove S, Miaka Mia Bilenge C, Būscher P (February 2007). "Equivalence trial of melarsoprol and nifurtimox monotherapy and combination therapy for the treatment of second-stage Trypanosoma brucei gambiense sleeping sickness". The Journal of Infectious Diseases. 195 (3): 322–329. doi:10.1086/510534. PMID 17205469. S2CID 10175400.
Kioy D, Jannin J, Mattock N (March 2004). "Human African trypanosomiasis". Nature Reviews. Microbiology. 2 (3): 186–187. doi:10.1038/nrmicro848. PMID 15751187. S2CID 36525641.
Brun R, Schumacher R, Schmid C, Kunz C, Burri C (November 2001). "The phenomenon of treatment failures in Human African Trypanosomiasis". Tropical Medicine & International Health. 6 (11): 906–914. doi:10.1046/j.1365-3156.2001.00775.x. PMID 11703845. S2CID 21542129.
Keiser J, Ericsson O, Burri C (May 2000). "Investigations of the metabolites of the trypanocidal drug melarsoprol". Clinical Pharmacology and Therapeutics. 67 (5): 478–488. doi:10.1067/mcp.2000.105990. PMID 10824626. S2CID 24326873.
Maudlin I (December 2006). "African trypanosomiasis". Annals of Tropical Medicine and Parasitology. 100 (8). Taylor & Francis: 679–701. doi:10.1179/136485906x112211. PMID 17227648. S2CID 19567898. ...cites this study: Fèvre EM, Coleman PG, Odiit M, Magona JW, Welburn SC, Woolhouse ME (August 2001). "The origins of a new Trypanosoma brucei rhodesiense sleeping sickness outbreak in eastern Uganda". Lancet. 358 (9282). Elsevier BV: 625–628. doi:10.1016/s0140-6736(01)05778-6. PMID 11530149. S2CID 205937568.

semanticscholar.org

api.semanticscholar.org

Bisser S, N'Siesi FX, Lejon V, Preux PM, Van Nieuwenhove S, Miaka Mia Bilenge C, Būscher P (February 2007). "Equivalence trial of melarsoprol and nifurtimox monotherapy and combination therapy for the treatment of second-stage Trypanosoma brucei gambiense sleeping sickness". The Journal of Infectious Diseases. 195 (3): 322–329. doi:10.1086/510534. PMID 17205469. S2CID 10175400.
Kioy D, Jannin J, Mattock N (March 2004). "Human African trypanosomiasis". Nature Reviews. Microbiology. 2 (3): 186–187. doi:10.1038/nrmicro848. PMID 15751187. S2CID 36525641.
Brun R, Schumacher R, Schmid C, Kunz C, Burri C (November 2001). "The phenomenon of treatment failures in Human African Trypanosomiasis". Tropical Medicine & International Health. 6 (11): 906–914. doi:10.1046/j.1365-3156.2001.00775.x. PMID 11703845. S2CID 21542129.
Keiser J, Ericsson O, Burri C (May 2000). "Investigations of the metabolites of the trypanocidal drug melarsoprol". Clinical Pharmacology and Therapeutics. 67 (5): 478–488. doi:10.1067/mcp.2000.105990. PMID 10824626. S2CID 24326873.
Maudlin I (December 2006). "African trypanosomiasis". Annals of Tropical Medicine and Parasitology. 100 (8). Taylor & Francis: 679–701. doi:10.1179/136485906x112211. PMID 17227648. S2CID 19567898. ...cites this study: Fèvre EM, Coleman PG, Odiit M, Magona JW, Welburn SC, Woolhouse ME (August 2001). "The origins of a new Trypanosoma brucei rhodesiense sleeping sickness outbreak in eastern Uganda". Lancet. 358 (9282). Elsevier BV: 625–628. doi:10.1016/s0140-6736(01)05778-6. PMID 11530149. S2CID 205937568.

web.archive.org

"Our Formulary". Infectious Diseases Laboratories. CDC. 22 September 2016. Archived from the original on 16 December 2016. Retrieved 7 December 2016.
"Melarsoprol Drug Information, Professional". Drugs.com. 20 December 1994. Archived from the original on 30 December 2016. Retrieved 7 December 2016.
"WHO Model Prescribing Information: Drugs Used in Parasitic Diseases - Second Edition: Protozoa: African trypanosomiasis: Melarsoprol". WHO. 1995. Archived from the original on 2016-11-10. Retrieved 2016-11-09.
"Trypanosomiasis, human African (sleeping sickness)". World Health Organization. February 2016. Archived from the original on 4 December 2016. Retrieved 7 December 2016.
CDC (2013). "Disease Control and Prevention: Parasites – African Trypanosomiasis". Archived from the original on 2017-06-19.
Pepin J (2014). "Trypanosoma brucei gambiense and Trypanosoma brucei rhodesiense (African Trypanosomiasis) - Infectious Disease and Antimicrobial Agents". antimicrobe.org. Archived from the original on 2016-11-28. Retrieved 2016-11-17.
Hollingham R (2005). "Curing diseases modern medicine has left behind". New Scientist. 2005 (2482): 40–41. Archived from the original on 2015-05-11.

who.int

"Trypanosomiasis, human African (sleeping sickness)". World Health Organization. February 2016. Archived from the original on 4 December 2016. Retrieved 7 December 2016.
"WHO renews agreement with sanofi-aventis". who.int. Retrieved 15 February 2022.

apps.who.int

"WHO Model Prescribing Information: Drugs Used in Parasitic Diseases - Second Edition: Protozoa: African trypanosomiasis: Melarsoprol". WHO. 1995. Archived from the original on 2016-11-10. Retrieved 2016-11-09.